Over 140,000 bottles of a prescription statin have been recalled due to "failed dissolution specifications," according to a U.S. Food and Drug Administration (FDA) enforcement report .

Ascend Laboratories of New Jersey pulled Atorvastatin Calcium, a drug sold as a generic version of Lipitor, that were manufactured by Alkem Laboratories of India and distributed nationwide. The recall, issued on Sept. 19, covers tablets packaged in 90-count, 500-count and 1,000-count bottles with expiration dates as late as February 2027.

On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the federal agency indicates that the recalled medications could cause "temporary or medically reversible adverse health consequences," but that the

See Full Page